Micrus Endovascular Corporation Fiscal Fourth Quarter Neurovascular Revenues Increase 24% to $25.6 Million

May 6, 2010 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

SAN JOSE, Calif.--(BUSINESS WIRE)--Micrus Endovascular Corporation (Nasdaq: MEND) today reported financial results for the three and 12 months ended March 31, 2010 and introduced fiscal 2011 financial guidance.

Twitter
LinkedIn
Facebook
Email
Print

Earnings